Outcome of treatment of human brucellosis in a study conducted in 2021 in Ghindae Zonal Referral Hospital, Eritrea (n = 393).

Table 3: Outcome of treatment of human brucellosis in a study conducted in 2021 in Ghindae Zonal Referral Hospital, Eritrea (n = 393).

Variable	Category	Outcome of Treatment
Variable	Category	Improved N (%)	Not improved N (%)	Referred N (%)	P-value
Age	< 8 years	35 (97.2)	1 (2.8)	0 (0.0)	0.09
	8 to 14 years	66 (98.5)	1 (1.5)	0 (0.0)
	15 to 60 years	139 (92.1)	2 (1.3)	10 (6.6)
	> 60 years	9 (100)	0 (0.0)	0 (0.0)
Sex	Male	141 (92.8)	3 (2.0)	8 (5.3)	0.266
Sex	Female	108 (97.3)	1 (0.9)	2 (1.8)	0.266
Doxycycline plus Gentamicin	Treated	212 (95.5)	3 (1.3)	7 (3.2)	0.459
Doxycycline plus Gentamicin	Another regimen given	37 (97.4)	1 (2.6)	0 (0)	0.459
Duration of Doxycycline	< 35 days	1 (33.3)	2 (66.7)	0 (0)	< 0.001
	35 to 39 days	16 (100)	0 (0)	0 (0)
	40 to 45 days	193 (97.5)	1 (0.5)	4 (2.0)
Duration of Gentamicin	< 7 days	1 (100)	0 (0)	0 (0)	< 0.001
	7 to 10 days	174 (97.8)	3 (1.7)	1 (0.6)
	11 to 14 days	72 (96)	0 (0)	3 (4)
	> 14 days	1 (50)	1 (50)	0 (0)
Duration of Cotrimoxazole	< 35 days	0 (0)	0 (0)	0 (0)	0.304
	35 to 39 days	2 (100)	0 (0)	0 (0)
	40 to 45 days	36 (97.3)	1 (2.7)	0 (0)

Treated: Received the corresponding regimen in the table; Another regimen given: Alternative regimen was given.
*: Discrepancies in n are due to missing values; N: frequency